Integrated Pharmaceuticals, Inc. Announces Shipping of its Unique Calcium Supplementation Product
November 01 2005 - 9:19AM
PR Newswire (US)
FITCHBURG, Mass., Nov. 1 /PRNewswire-FirstCall/ -- Integrated
Pharmaceuticals, Inc. (IntePharm) (OTC:INTP) announced today that
it has started shipping its proprietary calcium supplement product.
In addition to its calcium product, the Company is also routinely
shipping other portfolio products from its Fitchburg facility to
its distributors. IntePharm's specialty calcium product can be
added to hot and cold beverages and does not noticeably affect the
taste or flavor of the beverage. It makes more than 98% of its
calcium available for absorption. "To the best of IntePharm's
knowledge, no other manufacturer has a similar product on the
market," said Dr. Chinmay Chatterjee, President and CEO of
Integrated Pharmaceuticals, Inc. Dr. Chatterjee mentioned that its
calcium product will provide one of the most essential minerals of
human body, calcium, in a very user friendly manner in every drink.
According to USDA, the Center for Disease Control (CDC), and the
Office of Women's Health, 2000, over 90% of females, 70% of
infants, 66% of children and 60% of men are calcium deficient every
day. "This is a very alarming statistic. We are proud that
IntePharm is continuously working to bring an effective solution
for this large and long lasting worldwide problem," said Dr.
Chatterjee. "Taking adequate amounts of calcium every day in the
most absorbable format should be one of the lifestyle choices, like
maintaining appropriate weight and a weight-bearing exercise
regimen that plays a significant positive role in maintaining bone
health." A large number of scientific studies confirm the important
role of calcium in human metabolism, especially in the prevention
of age-related bone loss, osteoporosis and high blood pressure.
Several recent studies suggest that calcium may have a positive
effect on other chronic disorders. Shortage of calcium through low
regular calcium intake has been associated with an increased risk
for colon cancer, kidney stones, toxemia of pregnancy, pre-
menstrual syndrome, obesity, and polycystic ovary syndrome in
addition to low bone mass/osteoporosis and high blood pressure.
"All of these chronic diseases are multifactorial, and low calcium
intake is only one aspect involved in each condition," according to
The National Calcium Initiative: A Strategic Overview published by
the State of Indiana in the year 2000. Dr. Chatterjee said that
IntePharm, with its intellectual property portfolio, is uniquely
positioned to deliver specialty application products to the growing
demand of pharmaceutical, new generation nutraceutical, functional
food and beverage industries. In recent years the market for
functional food is growing with understanding of diet/disease
links, aging population, rising health care costs, and advances in
biochemistry, food science, and knowledge in nutrition sciences.
Nutraceutical World, October 2005, reported the recent market
studies indicate the total functional beverage market grew 18% over
the last year and is currently posting total sales of $1.8 billion,
which includes beverages sold in both the natural and conventional
channels of distribution. It is expected that just the
lifestyle/wellness category may register $1 billion in sales this
year, as it continues to register double-digit growth. IntePharm's
mineral delivery products may become one of the pioneering
ingredients in these drinks. IntePharm is in active discussion with
several nationwide manufacturers, distributors and retailers for
distribution of its calcium product. "With expected increases of
current sales, IntePharm anticipates to become cash flow positive
by the third quarter 2006," said Dr. Chatterjee. About IntePharm
IntePharm is an emerging producer of pharmaceuticals, specialty
compounds for the pharmaceutical, nutraceutical and functional food
and beverage industries. In addition to manufacturing products,
IntePharm discovers and develops more efficient and cost-effective
manufacturing and mineral delivery processes. These processes are
developed using a comprehensive technology platform that combines
metabolic engineering, cellular genetics, advanced bioprocess
engineering, and computer simulation science. The company owns
several other pending patents for new products and technologies for
immediate commercialization in food and nutritional products
market. For further information please contact Dr. Chinmay
Chatterjee, Integrated Pharmaceuticals, Inc. (IntePharm), at (978)
696-0020, or visit http://www.intepharm.com/ DATASOURCE: Integrated
Pharmaceuticals, Inc. CONTACT: Dr. Chinmay Chatterjee, President
and CEO of Integrated Pharmaceuticals, Inc., +1-978-696-0020 Web
site: http://www.intepharm.com/
Copyright